Back to search

The Open University

Multi-omics Characterisation of Myxoid Liposarcoma and Investigation of Trabectedin Mechanism of Action for Its Treatment

Abstract

dc:description.abstract

Myxoid liposarcoma (MLPS) is a rare soft tissue sarcoma of the mesenchymal cells characterised by the expression of the FUS-DDIT3 oncoprotein that impairs the adipocyte differentiation. Among the available therapeutic choices for the treatment of MLPS, trabectedin has shown significant anti-tumour activity. Although prolonged treatment is well-tolerated, recurrence of the resistant tumour invariably occurs even in initially responder patients. With the aim to characterise yet unknown molecular mechanisms of trabectedin mode of action and of resistance in MLPS, we integrated genomic, transcriptomic and protein-DNA binding data from patient-derived MLPS xenograft model, ML017, and its trabectedin-resistant derivate, ML017/ET. <br></br><br></br> DNA-Seq analysis showed that acquired-resistance to trabectedin may be due to the loss of genetic material in the <i>4p15.2, 4p16.3</i> and <i>17q21.3</i> cytobands and to the consequent inhibition of the genes mapping on these regions. Integration of longitudinal RNA-Seq and ChIP-Seq data revealed a two-phases mechanism of action of trabectedin. An early phase, characterised by the cytotoxic action of trabectedin and probably independent from FUS-DDIT3 activity; a second late phase, led by the DNA-binding activity of the chimera. Indeed, trabectedin displaces FUS-DDIT3 from most of its targets and modulates the transcription of the related genes involved in processes that sustain adipocyte differentiation. To note, no such differences were observed in ML017/ET resistant model. <br></br><br></br> These results shed light on the complex mechanism of action of trabectedin in MLPS. They provide insights into the process leading to drug resistance and can be the basis for the development of novel combinatorial strategies for the treatment of MLPS.

Degree

thesis:*
Name dc:type.qualificationname
phd
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
The Open University
Year dc:date.issued
2022

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Mannarino, Laura

Rights

Language dc:language
en

Chain of custody

source
Harvested from
The Open University
Base URL
oro.open.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Mannarino, Laura. Multi-omics Characterisation of Myxoid Liposarcoma and Investigation of Trabectedin Mechanism of Action for Its Treatment. doctoral thesis, The Open University, 2022.